Sanofi SA - Free Cash Flow To Equity
Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Free-Cash-Flow-To-Equity" stands at 3.84 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2019.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.37 Billion Euros compared to the value the year prior.
The 1 year change is 6.37 Billion Euros.
The 3 year change is 10.24 Billion Euros.
The 5 year change is 9.45 Billion Euros.
The Serie's change in Euros from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +11.14 Billion.
The Serie's change in Euros from it's maximum value, on 06/30/2018, to it's latest available value, on 09/30/2025, is -2.61 Billion.
Free Cash Flow To Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Free Cash Flow To Equity | 905,699,262,464.00 |
 | Johnson & Johnson - Free Cash Flow To Equity | 486,508,953,600.00 |
 | AbbVie Inc - Free Cash Flow To Equity | 399,570,305,024.00 |
 | Roche Holding AG - Free Cash Flow To Equity | 317,433,206,677.55 |
 | AstraZeneca PLC - Free Cash Flow To Equity | 280,205,508,085.11 |